Swiss National Bank lifted its holdings in Tilray Inc (NASDAQ:TLRY – Get Rating) by 9.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 1,295,138 shares of the company’s stock after purchasing an additional 114,900 shares during the quarter. Swiss National Bank owned about 0.21% of Tilray worth $3,484,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of the business. Prentice Capital Management LP bought a new stake in Tilray in the 3rd quarter valued at approximately $2,908,000. Thrivent Financial for Lutherans bought a new stake in shares of Tilray during the 2nd quarter worth approximately $2,212,000. Cubist Systematic Strategies LLC bought a new stake in shares of Tilray during the 2nd quarter worth approximately $1,186,000. Monaco Asset Management SAM bought a new stake in shares of Tilray during the 4th quarter worth approximately $740,000. Finally, California Public Employees Retirement System raised its stake in shares of Tilray by 27.2% during the 3rd quarter. California Public Employees Retirement System now owns 1,036,155 shares of the company’s stock worth $2,849,000 after purchasing an additional 221,482 shares in the last quarter. 11.59% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on TLRY. Atb Cap Markets reiterated a “sector perform” rating on shares of Tilray in a research note on Thursday, February 9th. Roth Capital reiterated a “neutral” rating on shares of Tilray in a research note on Wednesday, April 12th. Finally, TD Cowen dropped their price objective on Tilray from $9.00 to $5.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 11th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $4.74.
Tilray Stock Down 1.2 %
Tilray (NASDAQ:TLRY – Get Rating) last issued its quarterly earnings data on Monday, April 10th. The company reported ($1.90) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($1.84). Tilray had a negative net margin of 294.54% and a negative return on equity of 6.51%. The firm had revenue of $145.59 million during the quarter, compared to analyst estimates of $150.13 million. During the same period in the prior year, the company earned $0.04 earnings per share. The business’s quarterly revenue was down 4.1% compared to the same quarter last year. On average, sell-side analysts anticipate that Tilray Inc will post -0.28 earnings per share for the current year.
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
- Get a free copy of the StockNews.com research report on Tilray (TLRY)
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.